Annual report pursuant to Section 13 and 15(d)

Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders??? Equity and Cash Flows - Restatement To Previously Issued Condensed Consolidated Financial Statements (Details)

v3.8.0.1
Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders’ Equity and Cash Flows - Restatement To Previously Issued Condensed Consolidated Financial Statements (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2017
Sep. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Total other expense, net $ 487 $ 21 $ 1,290 $ 1,311 $ 1,797      
Total net loss/comprehensive loss $ (2,069) $ (1,703) $ (512) $ (2,215) $ (4,284)      
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A convertible preferred stock      
Net loss attributable to common stockholders $ (2,069) $ (1,703) $ (512) $ (2,215) $ (4,284) $ (9,329,000) $ (14,763,000)  
Net loss per share attributable to common stockholders Basic and diluted $ (0.68) $ (0.56) $ (0.18) $ (0.76) $ (1.47) $ (3.13) $ (13.63)  
Weighted average common shares outstanding: Basic and diluted 3,022,073 3,022,073 2,826,469 2,918,240 2,918,240 2,978,904 1,543,735  
Common stock, $0.01 par value $ 30 $ 30 $ 30 $ 30 $ 30 $ 30,000 $ 22,000  
Additional paid-in capital 225,733 225,491 225,432 225,491 225,733 226,041,000 222,513,000  
Accumulated deficit (215,323) (213,254) (211,511) (213,254) (215,323) (220,629,000) (211,300,000)  
Total stockholders' equity 10,440 12,267 13,911 12,267 10,440 $ 5,442,000 11,235,000 $ 14,332,000
Derivative liabilities, current portion 1,031 1,776 2,179 1,776 1,031      
As Previously Reported [Member]                
Total other expense, net (259) (382) (348) (730) (989)   (5,063)  
Total net loss/comprehensive loss $ (2,815) $ (2,106) $ (2,150) $ (4,256) $ (7,070)   $ (16,598)  
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A convertible preferred stock   (6,278)  
Net loss attributable to common stockholders $ (2,815) $ (2,106) $ (2,150) $ (4,256) $ (7,070)   $ (22,876)  
Net loss per share attributable to common stockholders Basic and diluted $ (0.93) $ (0.06) $ (0.06) $ (0.12) $ (242)   $ (14.82)  
Weighted average common shares outstanding: Basic and diluted 3,022,073 3,022,073 2,826,469 2,918,240 2,918,240   1,543,735  
Common stock, $0.01 par value $ 30 $ 30 $ 30 $ 30 $ 30   $ 22  
Additional paid-in capital 231,647 231,404 231,345 231,404 231,647   227,486  
Accumulated deficit (220,206) (217,391) (215,285) (217,391) (220,206)   (213,135)  
Total stockholders' equity 11,471 14,043 16,090 14,043 11,471   14,373  
Derivative liabilities, current portion    
Restatement - Warrant Liability [Member]                
Total other expense, net             1,835  
Total net loss/comprehensive loss             $ 1,835  
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A convertible preferred stock              
Net loss attributable to common stockholders             $ 1,835  
Net loss per share attributable to common stockholders Basic and diluted             $ 1.19  
Weighted average common shares outstanding: Basic and diluted              
Common stock, $0.01 par value              
Additional paid-in capital             (4,973)  
Accumulated deficit             1,835  
Total stockholders' equity             (3,138)  
Derivative liabilities, current portion             3,137  
As Restated After Restatement [Member]                
Total other expense, net             (3,228)  
Total net loss/comprehensive loss             $ (14,763)  
Deemed dividend related to beneficial conversion feature and accretion of a discount Series A convertible preferred stock             (6,278)  
Net loss attributable to common stockholders             $ (21,041)  
Net loss per share attributable to common stockholders Basic and diluted             $ (13.63)  
Weighted average common shares outstanding: Basic and diluted             1,543,735  
Common stock, $0.01 par value             $ 22  
Additional paid-in capital             222,513  
Accumulated deficit             (211,300)  
Total stockholders' equity             11,235  
Derivative liabilities, current portion             $ 3,137